Cardiovascular assessment in horses sedated with xylazine or amitraz

5Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Cardiovascular effects due to intravenous (IV) xylazine (1.0mg/kg) or amitraz (0.1 or 0.4mg/kg) were evaluated in horses. Left ventricular function indexes, heart rate (HR), and cardiac output (CO) were measured by echocardiography. Second degree atrioventricular (AV) block was detected by electrocardiography. Invasive arterial blood pressure (AP) was also evaluated. All parameters were measured immediately before and during 60 minutes after drug injection. HR, CO, and second degree AV block were different between xylazine and amitraz-0.4mg/kg groups. Xylazine induced initial hypertension 10 minutes after injection, and hypotension was observed 30 minutes after amitraz-0.4mg/kg administration. Except for the second degree AV block which occurred only at five minutes, there was no change in the echocardiographic measurements after administration of amitraz-0.1mg/kg. Thus, amitraz-0.4mg/kg and xylazine (1.0mg/kg) induced similar cardiovascular side effects, but longlasting action of amitraz-0.4mg/kg in the cardiovascular system was observed.

Cite

CITATION STYLE

APA

Linardi, R. L., Canola, J. C., & Valadão, C. A. A. (2008). Cardiovascular assessment in horses sedated with xylazine or amitraz. Arquivo Brasileiro de Medicina Veterinaria e Zootecnia, 60(2), 329–334. https://doi.org/10.1590/S0102-09352008000200008

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free